b.well and myTomorrows Partner to Transform Clinical Trial Access for Patients

Details

b.well Connected Health (b.well) is a healthcare technology company specializing in unifying fragmented health data into AI-ready longitudinal records. myTomorrows is a global health technology company that connects patients and physicians to pre-approval treatments. The partnership combines b.well's FHIR-based platform with myTomorrows' proven AI-powered clinical trial pre-screening and matching technology. b.well's platform integrates data from nearly 2.4 million providers, over 330 health plans, multiple state HIEs, laboratories, pharmacies, and over 350 wearables/biomarkers into complete, verified health data. Together, the companies enable pharmaceutical sponsors and trial sites to compliantly identify, screen, and enroll eligible patients faster while reducing the burden on individuals navigating challenging times. The integration allows automated eligibility matching using myTomorrows' AI platform against b.well’s unified longitudinal records, eliminating duplicative data gathering. This addresses the persistent need for enrolling more diverse patient populations while cutting time and cost in traditional recruitment. The collaboration reflects a broader shift toward transparent, real-time use of health data across the healthcare ecosystem to accelerate insights and support coordinated decision-making. The partnership aims to bring the best of health data unification and clinical trial matching technology to market, opening a new chapter in how the industry approaches clinical trial recruitment at scale.